| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.23 | 9e-07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |